Biomedical Research Center EPLS   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: St. Louis Senegal (1992)

Organization Overview

First Clinical Trial
2016
NCT03041766
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Biomedical Research Center EPLS | Biomedical Research Centre SAS

Active Ingredients

Drugs in Phase 3 Trials (2)

bacille calmette-guerin (1 trial)

mtbvac (1 trial)

Drugs in Phase 2 Trials (2)

gla-se (3 trials)

sm14 vaccine (3 trials)

Drugs in Other Trials (1)

l-carnosine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Schistosomiasis (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 5